Free Trial

Phibro Animal Health Corporation (NASDAQ:PAHC) Shares Bought by Hussman Strategic Advisors Inc.

Phibro Animal Health logo with Medical background

Hussman Strategic Advisors Inc. grew its position in Phibro Animal Health Corporation (NASDAQ:PAHC - Free Report) by 20.0% during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 126,000 shares of the company's stock after buying an additional 21,000 shares during the period. Hussman Strategic Advisors Inc. owned 0.31% of Phibro Animal Health worth $2,691,000 at the end of the most recent quarter.

Other institutional investors have also modified their holdings of the company. Point72 Asia Singapore Pte. Ltd. acquired a new stake in Phibro Animal Health in the 4th quarter worth approximately $29,000. Lazard Asset Management LLC boosted its stake in Phibro Animal Health by 2,739.7% in the 4th quarter. Lazard Asset Management LLC now owns 1,647 shares of the company's stock worth $34,000 after purchasing an additional 1,589 shares in the last quarter. Aquatic Capital Management LLC acquired a new stake in Phibro Animal Health in the 4th quarter worth approximately $69,000. Virtus Fund Advisers LLC acquired a new stake in Phibro Animal Health in the 4th quarter worth approximately $69,000. Finally, Quantbot Technologies LP boosted its stake in Phibro Animal Health by 65.1% in the 4th quarter. Quantbot Technologies LP now owns 5,116 shares of the company's stock worth $107,000 after purchasing an additional 2,018 shares in the last quarter. 99.34% of the stock is currently owned by institutional investors.

Phibro Animal Health Price Performance

PAHC traded down $0.26 during midday trading on Monday, hitting $29.16. 82,274 shares of the company traded hands, compared to its average volume of 224,424. The company has a current ratio of 2.91, a quick ratio of 1.23 and a debt-to-equity ratio of 2.67. The company has a market capitalization of $1.18 billion, a price-to-earnings ratio of 37.46, a PEG ratio of 0.49 and a beta of 0.75. Phibro Animal Health Corporation has a 52-week low of $16.16 and a 52-week high of $31.80. The business has a 50 day simple moving average of $25.77 and a two-hundred day simple moving average of $22.78.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last posted its quarterly earnings data on Wednesday, May 7th. The company reported $0.63 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.52 by $0.11. The business had revenue of $347.80 million for the quarter, compared to the consensus estimate of $352.41 million. Phibro Animal Health had a net margin of 2.68% and a return on equity of 30.51%. On average, equities analysts forecast that Phibro Animal Health Corporation will post 1.95 earnings per share for the current fiscal year.

Phibro Animal Health Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Wednesday, June 25th. Stockholders of record on Wednesday, June 4th were issued a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a dividend yield of 1.65%. The ex-dividend date was Wednesday, June 4th. Phibro Animal Health's payout ratio is 61.54%.

Wall Street Analyst Weigh In

Several analysts have commented on the stock. BNP Paribas upgraded shares of Phibro Animal Health to a "hold" rating in a research note on Monday, June 16th. JPMorgan Chase & Co. upgraded shares of Phibro Animal Health from a "neutral" rating to an "overweight" rating and lifted their price objective for the company from $25.00 to $35.00 in a research note on Monday, July 7th. BNP Paribas Exane raised shares of Phibro Animal Health from an "underperform" rating to a "neutral" rating and set a $24.00 target price for the company in a report on Monday, June 16th. Wall Street Zen raised shares of Phibro Animal Health from a "hold" rating to a "buy" rating in a report on Friday, May 9th. Finally, Morgan Stanley set a $26.00 target price on shares of Phibro Animal Health and gave the company an "equal weight" rating in a report on Wednesday, June 25th. Two investment analysts have rated the stock with a sell rating, three have assigned a hold rating and two have issued a buy rating to the company's stock. Based on data from MarketBeat, the company has a consensus rating of "Hold" and a consensus target price of $24.40.

Check Out Our Latest Research Report on Phibro Animal Health

Phibro Animal Health Company Profile

(Free Report)

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.

See Also

Institutional Ownership by Quarter for Phibro Animal Health (NASDAQ:PAHC)

Should You Invest $1,000 in Phibro Animal Health Right Now?

Before you consider Phibro Animal Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Phibro Animal Health wasn't on the list.

While Phibro Animal Health currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Overlooked Stocks Riding the AI Data Center Boom
3 Growth Stock Winners to Watch And 3 to Avoid
3 Growth Stocks That Could Pop Before Summer Ends

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines